Results 191 to 200 of about 9,009,506 (353)
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Workplace precrastination: conceptualization and scale development. [PDF]
Guo J, Cho I, Nifadkar S.
europepmc +1 more source
Measuring Cognitive Errors: Initial Development of the Cognitive Distortions Scale (CDS)
Roger Covin +3 more
openalex +2 more sources
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor +2 more
wiley +1 more source
Adolescents' attitudes towards healthy eating: A scale development study. [PDF]
Eşkil R, Eşkil KG, Yarım İ.
europepmc +1 more source
Insights into a long life without cancer: The case of the bowhead whale
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley +1 more source
Stigma related to male-factor infertility in China: a scale development and validation study. [PDF]
Zou F +8 more
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
A Bifactor Measure of Societal Stigma Toward Eating Disorders and Obesity: Scale Development and Validation. [PDF]
Suso-Ribera C +4 more
europepmc +1 more source

